Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Addictions
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Addictions
    TopAbstracts in Addictions 06/25/2009 - (DGNews)
    Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study - (BMJ)
    TopAbstracts in Addictions 06/11/2009 - (DGNews)
    TopAbstracts in Addictions 05/28/2009 - (DGNews)
    Evidence Supports Use of Online-Based Programs to Help Adults Quit Smoking - (DGNews)

    News archive

     Recent webcasts/CME - Addictions
      Proper Management of Patients with Controlled Substances: 5 Illustrative Cases
      Identifying and Treating Problem Drinkers
      Fetal Alcohol Spectrum Disorders (FASD): What it as and How it Affects the Child, the Family and Society: FASD and its Effects II
      Fetal Alcohol Spectrum Disorders (FASD): What it is and How it Affects the Child, the Family and Society: FASD and its Effects I
      More Than Brief Intervention: Updating Smoking Cessation Treatment for Pulmonary Patients

      Webcasts/CME archive

       Recent cases - Addictions
        Rare Case of Cefotaxime Induced Leukocytoclastic Vasculitis in Alcoholic Cirrhosis Patient
        Cystitis Due to the Use of Ketamine as a Recreational Drug: A Case Report
        Decrease in Tobacco Consumption After Treatment with Topiramate and Aripiprazole
        Calcific Myofibrosis Due to Pentazocine Abuse: A Case Report
        A Novel SPINK1 Gene Mutation, c.206C>T, in a Thai Patient with Chronic Alcoholic Pancreatitis

        Cases archive
          




        my personal edition > addictions > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Alcohol Treatment Medication, Behavioral Therapy Effective for Treating Cocaine Addiction

        WASHINGTON, DC -- March 2, 2004 -- Results of a study funded by the National Institute on Drug Abuse (NIDA), National Institutes of Health, suggest that disulfiram, a medication used to treat alcohol addiction, is effective in combating cocaine abuse. The researchers also conclude in the same study that combining disulfiram with behavioral therapy provides more positive results in treating cocaine dependence than disulfiram in combination with another form of therapy. The research is published in the March 2004 issue of the Archives of General Psychiatry.

        In the study, 121 cocaine-dependent individuals randomly were assigned to receive disulfiram (also known as Antabuse) or a placebo, in addition to undergoing one of two behavioral therapy interventions. Participants received either cognitive behavioral therapy (CBT) or interpersonal psychotherapy (IPT) in individual sessions during the 12-week project. Results showed that participants given disulfiram reduced their cocaine use significantly compared with people given placebo. In addition, those who received disulfiram in combination with CBT reduced their cocaine use compared with those who received disulfiram in combination with IPT. Lead investigator Dr. Kathleen Carroll, of Yale University School of Medicine, and her colleagues also report that benefits seen with disulfiram and CBT were most pronounced for people who were not alcohol dependent or who abstained fully from alcohol during therapy.

        "About 60 percent of people dependent on cocaine also abuse alcohol, so it was thought you could reduce cocaine abuse by targeting the accompanying codependence on alcohol," says NIDA Director Dr. Nora D. Volkow. "But these results suggest that disulfiram exerts a direct effect on cocaine use, rather than reducing concurrent alcohol use. More research is needed about whether combining disulfiram with CBT provides an even more effective tool for treating cocaine dependence."

        Disulfiram is one of two medications approved by the Food and Drug Administration (FDA) for treating alcohol abuse. It interferes with the metabolism of alcohol, producing aversive reactions such as nausea and vomiting when alcohol is ingested. The FDA notes that aversive reactions may also occur when patients taking disulfiram use cocaine.

        Cognitive behavioral therapy (CBT) theory holds that surroundings strongly influence a person's thinking and behavior, so CB therapists teach their patients new ways of acting and thinking in response to their environments. In the case of CBT for addiction, patients are urged to avoid situations that lead to drug use and to practice drug refusal skills. Interpersonal psychotherapy (IPT) is based on the concept that many psychiatric disorders, including cocaine dependence, are related intimately to disorders in interpersonal functioning, which may be related to the origin or perpetuation of the disorders.


        SOURCE: National Institute on Drug Abuse



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send